What are the recent financial highlights of ENTERO HEALTHCARE SOLU L?

ENTERO HEALTHCARE SOLU L recently reported a total revenue of ₹4,790.90 Cr and a net profit margin of 1.88%. These metrics reflect the company’s consistent financial performance.

What are the key financial metrics of ENTERO HEALTHCARE SOLU L?

Key financial metrics include a trailing P/E ratio of 54.20329, forward P/E of 31.395609, book value of ₹386.946, price-to-book ratio of 2.9010508, and a market capitalization of ₹48.84 billion.

What does ENTERO HEALTHCARE SOLU L do?

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India. The company is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. It also offers nebulizers, digital thermometers, blood pressure monitors, and adult diapers. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Entero

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Entero

Latest updates related to Entero

Sr No.	Title	Sentiment
1	Apollo Trinity brings Senior Gastroenterologist from Chennai to Shillong for specialised care Hub News	🔄
2	International CME on gastroenterology The Tribune India	🔄
3	Entero Healthcare Solutions consolidated net profit rises 275.22% in the December 2024 quarter Business Standard	🔄
4	Entero Healthcare Solutions' Stock Soars, Hits New High Amidst Strong Performance MarketsMojo	🔄
5	Entero Health Standalone December 2024 Net Sales at Rs 101.15 crore, up 32.08% Y-o-Y Moneycontrol	🔄
6	Entero Therapeutics Announces Proposed Reverse Merger with GlobeNewswire	🔄
7	Analysts Have Been Trimming Their Entero Healthcare Solutions Limited (NSE:ENTERO) Price Target After Its Latest Report Simply Wall St	🔄
8	Entero Healthcare Solutions Files For Rs 1,000 Cr IPO To Fuel Growth BW Healthcare World	🔄
9	Entero Healthcare Solutions - Well-Placed To Consolidate Pharma Distribution: HDFC Securities NDTV Profit	🔄
10	ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc. - ENTO Business Wire	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

POSITRON LLOYDS HINDZINC UNITDSPR TATACHEM SHAH BHARATSE MOTHERSON TEJASCARGO INDIFRA